Here are five points:
1. An aging population, rising number of obese patients and increasing demand for minimally invasive surgeries are driving the non-fusion global spinal technologies and disc diagnostic devices market.
2. Reimbursement policies pose an obstacle to the market’s growth.
3. North America dominates the market, due to 50 percent of the U.S. population over the age of 40 years experiencing degenerative disc disease.
4. The Asia Pacific region will experience the most rapid growth because of a large population.
5. Medtronic, Stryker, Zimmer and DePuy Synthes lead the market.
More articles on devices:
SeaSpine launches interbody device: 5 key notes
LDR, NuVasive, Spine Wave & more — 23 key notes
IlluminOss Medical names Manny Avila CEO: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
